Kleiner Perkins-backed Ambiq pops on IPO debut

Ambiq Micro, a 15-year-old company specializing in energy-efficient chips for wearable and medical devices, made a strong debut on the public market with its IPO on July 30, 2025. The stock closed at $38.53 per share, a 61% increase from its initial $24 IPO price, valuing the company at approximately $656 million, up significantly from its $450 million private valuation in 2023. Ambiq positions itself to benefit from AI-driven growth by offering low-energy edge processors capable of integrating more intelligence and AI functionalities, as highlighted by CTO Scott Hanson. Financially, Ambiq reported a net loss of $8.3 million on $15.7 million in revenue for Q1 2025, showing a slight improvement compared to the same period in 2024. The company’s largest outside investors include Kleiner Perkins and Singapore’s state-backed EDB Investments. Notably, Kleiner Perkins partner Wen Hsieh has been a long-term